Development of novel therapeutic strategy that targets pancreatic β cells for diabetes mellitus

2020-1012-06
researcher's name
affiliation
research field
Pathological medical chemistry,General medical chemistry,Environmental physiology (including physical medicine and nutritional physiology)
keyword

background

● Asians, especially Japanese, fail to evoke a compensatory hyperplasia of islets in Type II diabetes
● Treatment of type I diabetes with insulin is associated with a fatal risk of hypoglycemia

summary

● Increase in numbers of functional pancreatic β cells 
● Creation of pancreatic β-like cells by transdifferentiation

predominance

● New drug that targets directly on pancreatic cells 
● Realization of "curative" type I diabetes
● New therapeutic strategies for diabetes across types

application/development

● Medical industry

material

posted: 2020/10/27